APIS CYP2D6 dPCR Kit

About APIS Assay Technologies

APIS Assay Technologies is a commercial-stage diagnostics company with a dual business model of selling proprietary IVD kits and providing contract development services. Its core innovation is the Clickmer platform, a synthetic aptamer technology used to create high-affinity binding reagents for therapeutics, research, and diagnostics. The company has built a portfolio focused on oncology and pharmacogenomics, holds key ISO certifications, and operates with an integrated offering that includes assay development, bioinformatics, and regulatory support. APIS aims to translate biomarkers into clinical utility by helping diagnostics teams and biopharma companies accelerate from discovery to real-world impact.

Therapeutic Areas